Summary of Classification and Labelling
General Information
EC / List no.
|
Name |
CAS Number
|
|---|---|---|
| 611-907-1 | Cyclosporin A | 59865-13-3 |
Notified classification and labelling according to CLP criteria
| Classification | Labelling | Specific Concentration limits, M-Factors | Notes | Classification affected by Impurities / Additives
|
Additional Notified Information
|
Number of Notifiers
|
Joint Entries
|
||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Class and Category Code(s) | Hazard Statement Code(s) | Hazard Statement Code(s) | Supplementary Hazard Statement Code(s) | Pictograms, Signal Word Code(s) | |||||||
| Acute Tox. 4 | H302 | H302 |
GHS08 GHS07 Dgr |
State/Form
|
201 | View details | |||||
| Carc. 1B | H350 | H350 | |||||||||
| Repr. 1B | H360 | H360 | |||||||||
| Acute Tox. 4 | H302 | H302 |
GHS08 GHS07 Dgr |
State/Form
|
35 | View details | |||||
| Carc. 1B | H350 | H350 | |||||||||
| Repr. 1B | H360 | H360 | |||||||||
| STOT RE 1 | H372 (Kidney, liver, ...) | H372 | |||||||||
| Acute Tox. 4 | H302 | H302 |
GHS08 GHS07 Dgr |
28 | View details | ||||||
| Carc. 1B | H350 | H350 (May cause cance...) | |||||||||
| Repr. 1B | H360 (H360:May damage...) | H360 (May damage fert...) | |||||||||
| Acute Tox. 4 | H302 | H302 |
GHS08 GHS07 Dgr |
State/Form
|
2 | View details | |||||
| Carc. 1A | H350 | H350 | |||||||||
| Repr. 1B | H360 | H360 | |||||||||
| Lact. | H362 | H362 | |||||||||
| Acute Tox. 4 | H302 | H302 |
GHS08 GHS07 Dgr |
State/Form
|
2 | View details | |||||
| Carc. 1A | H350 | H350 | |||||||||
| Repr. 1B | H360 | H360 | |||||||||
| Acute Tox. 4 | H302 | H302 |
GHS08 GHS07 Wng |
State/Form
|
2 | View details | |||||
| Carc. 2 | H351 | H351 | |||||||||
| Aquatic Chronic 3 | H412 | H412 | |||||||||
| Acute Tox. 4 | H302 | H302 |
GHS08 Dgr |
Carc. 1A; : C ≥ .1 % |
State/Form
|
1 | View details | ||||
| Carc. 1B | H350 | H350 | |||||||||
| Lact. | H362 | H362 | |||||||||
| Acute Tox. 4 | H302 | H302 | EUH210 |
GHS08 GHS07 GHS06 Dgr |
Carc. 1B; : 98.5 % < C < 100 % Repr. 1B; : 98.5 % < C < 100 % 7534; : 98.5 % < C < 100 % |
State/Form
|
1 | View details | |||
| Carc. 1B | H350 | H350 | |||||||||
| Repr. 1B | H360 | H360 | |||||||||
| Acute Tox. 4 | H302 | H302 |
GHS08 GHS07 Dgr |
State/Form
|
1 | View details | |||||
| Carc. 1A | H350 (oral) | H350 | |||||||||
| Repr. 1A | H360 (oral) | H360 | |||||||||
| H302 |
GHS08 GHS07 Dgr |
State/Form
|
1 | View details | |||||||
| H350 | |||||||||||
| H361 | |||||||||||
| H373 | |||||||||||
| H412 | |||||||||||
| Acute Tox. 4 | H302 | H302 |
GHS08 GHS07 Dgr |
State/Form
|
1 | View details | |||||
| Carc. 1A | H350 | H350 | |||||||||
| Lact. | H362 | H362 | |||||||||
| Acute Tox. 4 | H302 | H302 |
GHS08 GHS07 Dgr |
State/Form
|
1 | View details | |||||
| Carc. 1A | H350 | H350 | |||||||||
| Repr. 2 | H361 | H361 | |||||||||
| Acute Tox. 4 | H302 | H302 |
GHS08 GHS07 Dgr |
1 | View details | ||||||
| Carc. 1A | H350 | H350 | |||||||||
| Repr. 2 | H361 (fd) | H361 (fd) | |||||||||
| Lact. | H362 | H362 | |||||||||
| Acute Tox. 4 | H302 | H302 |
GHS08 GHS07 Dgr |
State/Form
|
1 | View details | |||||
| Carc. 1A | H350 (dermal) | H350 | |||||||||
| STOT RE 1 | H372 (immune system, ...) (dermal,oral) | H372 | |||||||||
| H302 |
GHS01 GHS03 Dgr |
State/Form
|
1 | View details | |||||||
| H350 | |||||||||||
| H360 | |||||||||||
| Acute Tox. 4 | H302 | H302 |
GHS08 GHS07 Dgr |
1 | View details | ||||||
| Carc. 1A | H350 | H350 | |||||||||
| Repr. 2 | H361 (fd) | H361 | |||||||||
| Lact. | H362 | H362 | |||||||||
| Acute Tox. 4 | H302 | H302 |
GHS08 GHS07 Dgr |
State/Form
|
1 | View details | |||||
| Carc. 1B | H350 | H350 | |||||||||
| Repr. 1B | H360 | H360 | |||||||||
| STOT RE 1 | H372 (dermal,inhalati...) | H372 | |||||||||
Number of Aggregated Notifications: 17